Accendra Health on notice from NYSE
By HME News Staff
Updated 9:46 AM CDT, Mon October 12, 2026
RICHMOND, Va. – Accendra Health, Inc. on Oct. 6, 2026, received a notice from the New York Stock Exchange notifying the company that it is not in compliance with the NYSE’s continued listing standards because the average closing price of the company’s Class A Common Stock was less than $1.00 per share over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the company’s Common Stock from the NYSE, said Accendra in a release posted on its website. Accendra intends to respond to the NYSE within ten business days of receipt of the notice affirming its intent to cure the deficiency. Pursuant to the NYSE’s rules, the company has a six-month period following receipt of the notice to regain compliance with the NYSE’s minimum share price requirement. Accendra intends to consider a number of available alternatives to cure its non-compliance with the applicable price criteria in the NYSE’s continued listing standard.
Comments